Monday, February 1, 2016
Varadan, V., Kamalakaran, S., Gilmore, H., Banerjee, N., Janevski, A., Miskimen, K., ... Harris, L.
(2016).
Brief-exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER2-negative breast cancers..
International journal of cancer,
138
(3),
747-57.